Screening Genes Associated with Biological Signal Conduction and Immunity in Lung Squamous Cell Carcinoma by BiostarH-Ⅰ cDNA Microarray

Abstract

Abstract: Objective By use of cDNAmicroarray, to screen out the differential expression genes which are related with biological signal conduction, humoral or cellular immunity in lung squamous cell carcinoma and normal lung tissue.Methods The total RNAs were isolated from tumor and normal lung tissue and were reversely transcribed to prepare the hybridization probe.The mixed probes were hybridized with the BiostarH-Ⅰ cDNAmicroarray.After washing, the cDNAmicroarray was scanned for the fluorescent signals by ScanArray 4000 scaning apparatus.The scaning data was analyzed by Genepxix Pro software and differential expression genes between these two kinds of tissues were shown out.Results Eight strips of genes were screened out.Among them, five genes'expression level were up-regulated(r>2.0), including: METAP2, LIV-1, CUL2, CSE1L, RBBP2H1A, and the rest three strips were down-regulated(r<0.5), including: HBB, CKB, CX3CL1.Conclusion cDNAmicroarray can realize high-through out screening of the genes which associated with lung cancer.Eight genes which related with biological singal conduction or immunity in lung squamous cell carcinoma are found.Further investigation about these genes will be carried out later.

Key words: cDNA microarray, lung cancer, immunity, biological signal conduction

CLC Number:

R734.2

Bai Peng;Zhang Husheng;Wang Yuzhou. Screening Genes Associated with Biological Signal Conduction and Immunity in Lung Squamous Cell Carcinoma by BiostarH-Ⅰ cDNA Microarray[J]. Journal of Capital Medical University, 2005, 26(6): 729-732.

[1]	Yang Min, Yan Xiang, Liu Xijuan, An Guo, Ding Huirong, Cai Ying, Ge Huizheng. Establishment and characterization of immune cells in an orthotopic cell-derived xenograft mouse model of human lung cancer using multi-color flow cytometry [J]. Journal of Capital Medical University, 2023, 44(1): 99-106.
[2]	Zhang Jingtao, Wang Xinran, Han Binru, Qiang Ying, Liu Xueqi, Zhang Yi. Analysis of clinical characteristics and risk factors of arrhythmia after thoracoscopic pneumonectomy in elderly patients with lung cancer [J]. Journal of Capital Medical University, 2022, 43(4): 564-569.
[3]	Tan Xiaogang, Zhang Yi. Progress in neoadjuvant immunotherapy for resectable non-small cell lung cancer [J]. Journal of Capital Medical University, 2021, 42(5): 862-867.
[4]	Wang Weiwei, Wang Shanshan, Zhang Man. Clinical significance of kininogen 1 expression in non-small cell lung cancer biofluids and tissues [J]. Journal of Capital Medical University, 2021, 42(1): 77-82.
[5]	Wang Xin, Zhang Junxuan, Gao Jian, Shi Hanping. Immunonutrition improves the prognosis of patients with cancer [J]. Journal of Capital Medical University, 2020, 41(6): 1019-1024.
[6]	Li Shengao, Li Qi, Cao Chunjie, Dong Hongyu, Li Jie, Zhang Qiuhuan, Wang Jingyuan, Hua Haiqin, Wang Zhiqun. Value of multi-slice spiral CT low-dose scanning program in the argon-helium cryotherapy of lung cancer under the guidance of CT [J]. Journal of Capital Medical University, 2018, 39(2): 185-189.
[7]	Chen Chen, Meng Yan. Ang Ⅱ activates dendritic cell to produce immune function [J]. Journal of Capital Medical University, 2017, 38(5): 709-714.
[8]	Liu Baodong, Zhi Xiuyi. Interpretation and prospect of the eighth edition of TNM staging for lung cancer [J]. Journal of Capital Medical University, 2016, 37(6): 753-757.
[9]	Tan Xiaogang, Wang Ruotian, Yao Shuyang, Zhi Xiuyi. Meta analysis of the association between the polymorphism of XRCC1 Arg280His and lung cancer susceptibility [J]. Journal of Capital Medical University, 2016, 37(6): 758-762.
[10]	Hu Mu, Zhang Yi, Xu Qingsheng, Liu Baodong, Su Lei, Wang Ruotian, Zhi Xiuyi. Clinical study for resection range for early stage non-small cell lung cancer patients [J]. Journal of Capital Medical University, 2016, 37(6): 763-766.
[11]	Pan Shouqiang, Zhang Yi. Clinical evaluation of the factors related to the properties of the upper lobe of the lung [J]. Journal of Capital Medical University, 2016, 37(6): 767-772.
[12]	Yao Shuyang, Zhi Xiuyi. Adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for non-small cell lung cancer [J]. Journal of Capital Medical University, 2016, 37(6): 773-776.
[13]	Zhi Xiuyi, Yao Shuyang. Tumor markers in the whole management of lung cancer patients [J]. Journal of Capital Medical University, 2015, 36(6): 986-991.
[14]	Zhang Yi, Zhi Xiuyi. Minimally invasive surgery to treat early lung cancer [J]. Journal of Capital Medical University, 2015, 36(6): 992-997.
[15]	Yao Shuyang, Wang Xin, Li Xiaoxue, Zhang Yi, Zhi Xiuyi. Pattern of bone metastasis and treatment of Chinese patients with advanced non-small-cell lung cancer [J]. Journal of Capital Medical University, 2015, 36(4): 533-536.

Screening Genes Associated with Biological Signal Conduction and Immunity in Lung Squamous Cell Carcinoma by BiostarH-Ⅰ cDNA Microarray

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments